Christine A. Collins

ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis

Fred Poordad, Christophe Hézode, Roger Trinh et al. · New England Journal of Medicine · 2014 · 877 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Glecaprevir and Pibrentasvir in Patients with HCV and Severe Renal Impairment

Edward Gane, Eric Lawitz, David Pugatch et al. · New England Journal of Medicine · 2017 · 398 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +15

Molecular cloning of the microtubule-associated mechanochemical enzyme dynamin reveals homology with a new family of GTP-binding proteins

Robert A. Obar, Christine A. Collins, James A. Hammarback et al. · Nature · 1990 · 350 citations

Life Sciences, Cell Biology, Molecular Biology +11

Validation of Diacyl Glycerolacyltransferase I as a Novel Target for the Treatment of Obesity and Dyslipidemia Using a Potent and Selective Small Molecule Inhibitor

Gang Zhao, Andrew J. Souers, Martin J. Voorbach et al. · Journal of Medicinal Chemistry · 2008 · 140 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +17

<i>In Vitro</i> Antiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS5A Inhibitor Pibrentasvir

Teresa I. Ng, Preethi Krishnan, Warren M. Kati et al. · Antimicrobial Agents and Chemotherapy · 2017 · 139 citations · Full text

Medicine, Infectious Diseases, Pharmacology +17